NCT02182830[Secondary Source ID] - Search Results

Your saved search

Your RSS Feed

Year	Number of Results
2017	1
2018	1
2019	1
2020	1
2026	0

Page 1

Antihyperglycemic and Blood Pressure Effects of Empagliflozin in Black Patients With Type 2 Diabetes Mellitus and Hypertension.

Ferdinand KC, Izzo JL, Lee J, Meng L, George J, Salsali A, Seman L. Ferdinand KC, et al. Circulation. 2019 Apr 30;139(18):2098-2109. doi: 10.1161/CIRCULATIONAHA.118.036568. Circulation. 2019. PMID: 30786754 Clinical Trial.

Design of a 24-week trial of empagliflozin once daily in hypertensive black/African American patients with type 2 diabetes mellitus.

Ferdinand KC, Seman L, Salsali A. Ferdinand KC, et al. Curr Med Res Opin. 2018 Feb;34(2):361-367. doi: 10.1080/03007995.2017.1405800. Epub 2017 Nov 29. Curr Med Res Opin. 2018. PMID: 29139301 Clinical Trial.

The NEW-HOPE study and emerging therapies for difficult-to-control and resistant hypertension.

Ferdinand KC, Harrison D, Johnson A. Ferdinand KC, et al. Prog Cardiovasc Dis. 2020 Jan-Feb;63(1):64-73. doi: 10.1016/j.pcad.2019.12.008. Epub 2020 Jan 8. Prog Cardiovasc Dis. 2020. PMID: 31923435 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year